Zoetis | ZTS - Selling And Administration Expenses

Stock Price
128.78
Daily Change
1.50 1.18%
Monthly
2.96%
Yearly
-19.74%
Q1 Forecast
124.79

Zoetis reported $619M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
AbbVie USD 3.89B 325M Dec/2025
Align Technology USD 441.68M 23.88M Dec/2025
Bayer EUR 3.4B 140M Sep/2025
Bristol-Myers Squibb USD 2.18B 392M Dec/2025
Charles River Laboratories USD 196.14M 18.55M Dec/2025
Coherus Biosciences USD 26.02M 8.57M Mar/2025
Dentsply International USD 355M 21M Sep/2025
Eli Lilly USD 3.13B 391.3M Dec/2025
Henry Schein USD 760M 17M Sep/2025
Idexx Laboratories USD 275.68M 10.58M Dec/2025
Illumina USD 283M 27M Dec/2025
IQVIA Holdings USD 468M 46M Dec/2025
J&J USD 6.75B 831M Dec/2025
Laboratory Of America USD 538.6M 13.8M Dec/2025
Merck USD 2.85B 215M Dec/2025
Neogen USD 107.5M 1.56M Sep/2025
Pacira USD 91.8M 14.6M Sep/2025
Perrigo USD 245.7M 27.4M Sep/2025
Pfizer USD 4.08B 894M Dec/2025
Phibro Animal Health USD 76.34M 10.54M Dec/2024
Quest Diagnostics USD 504M 3M Dec/2025
Sanofi EUR 2.75B 455M Dec/2025
Sanofi EUR 2.75B 455M Dec/2025
Zoetis USD 619M 40M Dec/2025